AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Recruiting now · Not applicable

Conditions studied: Migraine

In brief

Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis, inadequate treatment, and stigmatization. AI can enhance migraine management through improved diagnosis, prediction, and personalized education. The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients' understanding of their condition more effectively.

Key facts

Study ID

NCT06507150

Run by

Ente Ospedaliero Cantonale, Bellinzona

People needed

140

Starts

2024-09-01

Expected to finish

2027-06-01

Last updated by the study team

2026-03-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• aged between 18 and 65 years at the time of signing the informed consent
• Newly diagnosis of migraine, confirmed through the medical chart
• The participant must be capable of giving signed informed consent
• Access to a laptop, computer, smartphone, or tablet

You may not qualify if…

• Insufficient knowledge of the protocol language (italian)
• Patients with cognitive impairment and/or unable to use or access the AI-powered learning platform developed in this study.
• Vulnerable participants (e.g. minors, participants incapable of judgment or participants under tutelage)

Where it is running

• Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano — Lugano, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.